As the global threat of drug-resistant infections accelerates, the pharmaceutical industry is losing ground, leaving vulnerable populations in sub-Saharan Africa dangerously exposed, according to the newly released 2026 Antimicrobial Resistance (AMR) Benchmark. The comprehensive report, published by the Access to Medicine Foundation, reveals a stark reality for the continent: across 17 sub-Saharan African countries, none […]The post Millions at risk as Pharma halts Superbug Research appeared first on Eagle Online.